ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
8,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
9,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
9,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
12,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
12,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
12,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
13,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
13,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
14,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
15,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
16,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
16,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
17,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
17,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
17,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
18,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
19,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
20,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
20,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
21,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
21,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
22,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
22,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
22,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
23,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
24,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
25,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
25,2,Spontaneous penile erection,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
26,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
27,1,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
28,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
29,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
29,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
29,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
29,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
29,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
30,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
31,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
32,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
32,2,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
32,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
33,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
34,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
35,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
35,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,3,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
36,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
36,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
37,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
37,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
38,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
38,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
39,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
39,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
40,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
41,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
42,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
42,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
42,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
42,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
43,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
44,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
45,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
46,1,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
47,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
47,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
48,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
48,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
49,1,Headache,Headaches NEC,Headaches,Nerv,N
50,1,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
51,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
51,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
52,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
53,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
53,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
54,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
55,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
56,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
57,1,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
58,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
59,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
60,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
61,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
62,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
63,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
64,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
64,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
65,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
66,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
66,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
66,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
67,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
67,2,Penile swelling,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
67,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
68,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
69,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
69,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
69,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
69,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
70,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
70,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
71,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
72,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
73,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
74,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
75,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
75,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
75,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
76,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
76,2,Burning sensation mucosal,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
76,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
76,4,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
76,5,Respiratory tract irritation,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
77,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
77,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
77,3,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
77,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
77,5,Genital burning sensation,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
77,6,Headache,Headaches NEC,Headaches,Nerv,N
77,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
77,8,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
77,9,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
77,10,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
77,11,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
78,1,Tension headache,Headaches NEC,Headaches,Nerv,N
79,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
80,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
80,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
80,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
80,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
81,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
81,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
82,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
82,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
82,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
82,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
83,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
83,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
84,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
84,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
85,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
85,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
85,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
85,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
85,5,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
86,1,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
87,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
88,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
88,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
89,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
90,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
91,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
91,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
92,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
93,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
93,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
93,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
94,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
95,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
96,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
96,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
96,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
97,1,Application site hypoaesthesia,Application site reactions,Administration site reactions,Genrl,N
98,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
98,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
99,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
100,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
101,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
101,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
101,3,Application site scar,Application site reactions,Administration site reactions,Genrl,N
101,4,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
101,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
101,6,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
101,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
101,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
101,9,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
101,10,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
102,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
102,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
102,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
103,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
104,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
105,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
105,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
106,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
106,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
107,1,Accelerated hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
107,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
107,3,Headache,Headaches NEC,Headaches,Nerv,N
108,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
108,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
109,1,Melanoma recurrent,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
110,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
110,2,Chemical burn of respiratory tract,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
111,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
111,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
111,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
112,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
112,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
112,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
113,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
113,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
113,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
114,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
115,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
116,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
116,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
116,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
116,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
116,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
116,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
117,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
117,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
117,3,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
117,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
118,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
119,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
119,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
120,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
121,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
121,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
122,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
122,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
122,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
122,4,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
123,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
124,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
125,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
125,2,Product deposit,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
126,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
126,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
127,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
127,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
127,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,4,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
127,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
127,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
128,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
128,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
128,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
129,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
129,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
129,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
129,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
130,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
130,2,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
131,1,Administration site swelling,Administration site reactions NEC,Administration site reactions,Genrl,N
132,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
132,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
133,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
133,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
133,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
134,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
134,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
135,1,Administration site swelling,Administration site reactions NEC,Administration site reactions,Genrl,N
135,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
136,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
136,2,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
136,3,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
137,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
137,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
137,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
137,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
138,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
139,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
140,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
140,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
140,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
141,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
142,1,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
143,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
143,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
144,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
144,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
144,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
144,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
144,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
144,6,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
145,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
145,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
145,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
145,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
145,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
145,6,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
146,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
147,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
147,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
149,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
149,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
150,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
151,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
152,1,Urge incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
153,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
153,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
154,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
155,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
155,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
155,3,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
155,4,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
156,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
156,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
157,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
158,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
158,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
159,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
160,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
160,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
160,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
161,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
161,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
161,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
162,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
163,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
163,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
163,3,Use of accessory respiratory muscles,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
164,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
165,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
165,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
165,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
166,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
166,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
167,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
167,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
167,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
167,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
167,5,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
167,6,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
168,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
168,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
168,3,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
168,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
169,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
170,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
171,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
172,1,Administration site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
172,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
173,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
173,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
173,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
173,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
173,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
173,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
174,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
175,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
175,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
175,3,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
176,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
176,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
176,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
177,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
177,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
177,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
177,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
177,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
178,1,Administration site hypersensitivity,Administration site reactions NEC,Administration site reactions,Genrl,N
179,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
179,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
180,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
181,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
181,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
182,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
183,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
183,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
184,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
184,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
184,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
184,4,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
185,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
186,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
186,2,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
186,3,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
186,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
186,5,Induced labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
186,6,Intrapartum haemorrhage,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
186,7,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
186,8,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
186,9,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
186,10,Prolonged labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
186,11,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
187,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
188,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
188,2,Eye allergy,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
189,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
190,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
190,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
191,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
191,2,Post herpetic neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
192,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
193,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
193,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
193,3,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
193,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
194,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
194,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
195,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
195,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
195,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
196,1,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
196,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
197,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
197,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
197,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
198,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
198,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
198,3,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
199,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
199,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
199,3,Exposure via inhalation,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
200,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
200,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
201,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
201,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
201,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
202,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
202,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
202,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
203,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
203,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
204,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
205,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
205,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
205,3,Hyperemesis gravidarum,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
205,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
205,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
206,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
206,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
206,5,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,7,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,8,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
207,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
208,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
208,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
208,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
209,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
210,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
210,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
211,1,Amniotic fluid volume decreased,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
211,2,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
211,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
212,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
212,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
213,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
214,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
214,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
214,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,1,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
215,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
215,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
215,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
216,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
216,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
216,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
217,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
218,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
218,2,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
218,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
218,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
218,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
218,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
219,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
219,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
219,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
220,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
220,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
220,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
221,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
221,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
222,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
222,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
223,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
223,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
224,1,Eyelid irritation,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
224,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
224,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
224,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
224,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
225,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
226,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
227,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
227,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
228,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
229,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
230,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
231,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
232,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
233,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
233,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
234,1,Bladder irritation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
234,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
234,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
234,4,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
235,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
235,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
236,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
237,1,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
237,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
237,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
238,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
239,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
239,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
240,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
241,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
241,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
242,1,Application site hypoaesthesia,Application site reactions,Administration site reactions,Genrl,N
243,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
244,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
245,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
245,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
245,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
246,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
246,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
246,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
247,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
247,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
